|
Prescription Drug Search
Strengths available for Zolinza:
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about MyGlobalPharmacy.com
List of countries where we can ship Zolinza:
- Albania
- Anguilla
- Austria
- Belgium
- Belize
- Bermuda
- Bosnia and Herzegovina
- Chile
- Colombia
- Estonia
- Finland
- Gibraltar
- Greece
- Greenland
- Guatemala
- Hong Kong
- Hungary
- India
- Japan
- Liechtenstein
- Lithuania
- Malta
- Mauritius
- Panama
- Philippines
- Romania
- Russian Federation
- Saint Lucia
- Seychelles
- Slovakia
- Sweden
- Switzerland
- Taiwan
- Tonga
- Tunisia
- Ukraine
- United Kingdom, UK
- United States, US
- Uzbekistan
- Vanuatu
Latest news releases on Zolinza:
Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3 - Xconomy
There are also more targeted drugs like Eisai Pharmaceuticals’ bexarotene (Targretin), Merck’s vorinostat (Zolinza), or Celgene’s romidepsin (Istodax). But once patients progress past the early rounds of therapy, no treatments have shown ...
Arno AR-42 for neurofibromatosis type 2 receives EMA orphan-drug designation - News-Medical.Net
AR-42 is a novel, orally available, broad-spectrum deacetylation inhibitor of both histone and non-histone proteins which has demonstrated greater potency and activity in solid tumors and hematological malignancies when compared in preclinical ...
Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality Reduction - msnbc.com
Vinorelbine (Navelbine), Vorinostat (Zolinza) and Zibotentan. For more information, visit: http://www.trimarkpublications.com/game-changers-in-breast-cancer-therapies.
Towards a cure for all: How we might do it - Aidsmap
This may be because valproic acid is not strong enough. Trials are planned of a stronger HDAC inhibitor called vorinostat (Zolinza), a cancer drug already used for some types of lymphoma and which is being trialled for anal cancer. 7 “Vorinostat is a ...
Arno Therapeutics Announces Orphan-Drug Designation for AR-42 in Europe - Yahoo Finance
Arno Therapeutics, Inc. (OTCBB: ARNI.OB - News) announced today that its investigational compound known as AR-42 has been granted orphan-drug designation by the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products for the ...
